SEC Form 4 · accession 0001209191-15-007498
TETRALOGIC PHARMACEUTICALS Corp · TLOG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas E Onsi
Director
Period of report
Jan 28, 2015
Accepted (ET)
Jan 29, 2015 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001361248
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.25 | Jan 28, 2015 | A | 10,000 | A | — | Jan 28, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Beginning on February 28, 2015, the shares underlying the stock option will vest and become exercisable in 12 equal monthly installments, subject to the reporting person's continued service as a director as of each vesting date.